These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2059436

  • 1. AZT resistance in isolates of HIV.
    Richman DD.
    Immunodefic Rev; 1991; 2(4):315-8. PubMed ID: 2059436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Resistance of human immunodeficiency virus (HIV) to zidovudine. Genotypic analysis in strains isolated from Chilean patients].
    Vial PA, Vial C, Abarca K, Noriega M, Jiménez G, Labarca J, Gasep J, Palacios O, Pérez C, Acuña G.
    Rev Med Chil; 1998 Jan; 126(1):17-26. PubMed ID: 9629750
    [Abstract] [Full Text] [Related]

  • 7. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
    Falkensammer B, El Attal R, Müllauer B, Sarcletti M, Parson W, Dierich MP, Stoiber H.
    Eur J Med Res; 2002 Sep 30; 7(9):379-86. PubMed ID: 12435615
    [Abstract] [Full Text] [Related]

  • 8. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 30; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [Abstract] [Full Text] [Related]

  • 9. Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.
    Rusconi S, De Pasquale MP, Mainini F, Bulgheroni E, Kurtagic S, Gori A, Violin M, Zanchetta N, Moroni M, Balotta C, Galli M.
    Antivir Ther; 1996 Dec 30; 1(4):211-9. PubMed ID: 11324823
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.
    Atkinson B, Isaacson J, Knowles M, Mazabel E, Patick AK.
    J Infect Dis; 2000 Aug 30; 182(2):420-7. PubMed ID: 10915071
    [Abstract] [Full Text] [Related]

  • 16. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
    Larder BA, Darby G, Richman DD.
    Science; 1989 Mar 31; 243(4899):1731-4. PubMed ID: 2467383
    [Abstract] [Full Text] [Related]

  • 17. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar 31; 10 Suppl 1():S57. PubMed ID: 8595510
    [Abstract] [Full Text] [Related]

  • 18. Roaches of inner space.
    Gilden D.
    GMHC Treat Issues; 1995 Oct 31; 9(10):1, 14-6. PubMed ID: 11362912
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.